How does treatment with ledipasvir/sofosbuvir impact the risk of a new occurrence and/or recurrence of hepatocellular carcinoma in patients with HCV?
Journal of Viral Hepatitis
Original Article: Recurrence of HCC Following LDV/SOF Treatment in Chronic HCV